133 related articles for article (PubMed ID: 36807890)
21. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
[TBL] [Abstract][Full Text] [Related]
22. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
de Mestier L; Neuzillet C; Pozet A; Desot E; Deguelte-Lardière S; Volet J; Karoui M; Kianmanesh R; Bonnetain F; Bouché O
Eur J Surg Oncol; 2014 Jun; 40(6):685-91. PubMed ID: 24630774
[TBL] [Abstract][Full Text] [Related]
23. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection.
Taner T; Atwell TD; Zhang L; Oberg TN; Harmsen WS; Slettedahl SW; Kendrick ML; Nagorney DM; Que FG
HPB (Oxford); 2013 Mar; 15(3):190-5. PubMed ID: 23374359
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of Liver-Directed Therapy and Systemic Therapy for the Treatment of Liver Metastases in Patients with Gastrointestinal Neuroendocrine Tumors: Analysis of the California Cancer Registry.
Kessler J; Singh G; Ituarte PHG; Allen R; Chang S; Li D
J Vasc Interv Radiol; 2021 Mar; 32(3):393-402. PubMed ID: 33358144
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes.
Aghayan DL; Kalinowski P; Kazaryan AM; Fretland ÅA; Sahakyan MA; Røsok BI; Pelanis E; Bjørnbeth BA; Edwin B
World J Surg Oncol; 2019 Sep; 17(1):156. PubMed ID: 31484583
[TBL] [Abstract][Full Text] [Related]
28. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database.
Jin S; Cho WC; Yang J; Xia K; Zhou C
Front Endocrinol (Lausanne); 2023; 14():1167508. PubMed ID: 37916151
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
31. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
J Neuroendocrinol; 2024 May; ():e13399. PubMed ID: 38760997
[TBL] [Abstract][Full Text] [Related]
32. The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases.
Mou Y; Wang ZY; Tan CL; Chen YH; Liu XB; Ke NW
Front Oncol; 2022; 12():838103. PubMed ID: 35350567
[TBL] [Abstract][Full Text] [Related]
33. Primary Tumor Resection Provides Survival Benefits for Patients with Synchronous Brain Metastases from Colorectal Cancer.
Cheng X; Li Y; Chen D; Xu X; Liu F; Zhao F
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885491
[TBL] [Abstract][Full Text] [Related]
34. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.
Zhao J; Zhu J; Sun R; Huang C; Yuan R; Zhu Z
BMC Cancer; 2021 May; 21(1):503. PubMed ID: 33957871
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
[TBL] [Abstract][Full Text] [Related]
36. Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis.
Chaiteerakij R; Chattieng P; Choi J; Pinchareon N; Thanapirom K; Geratikornsupuk N
Ann Hepatol; 2017; 16(3):421-429. PubMed ID: 28425412
[TBL] [Abstract][Full Text] [Related]
37. Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia.
Du S; Wang Z; Sang X; Lu X; Zheng Y; Xu H; Xu Y; Chi T; Zhao H; Wang W; Cui Q; Zhong S; Huang J; Mao Y
Medicine (Baltimore); 2015 Jan; 94(2):e388. PubMed ID: 25590842
[TBL] [Abstract][Full Text] [Related]
38. Determinants of survival following hepatic resection for metastatic colorectal cancer.
Bakalakos EA; Kim JA; Young DC; Martin EW
World J Surg; 1998 Apr; 22(4):399-404; discussion 404-5. PubMed ID: 9523523
[TBL] [Abstract][Full Text] [Related]
39. Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.
Klatte T; Fife K; Welsh SJ; Sachdeva M; Armitage JN; 'Aho T; Riddick AC; Matakidou A; Eisen T; Stewart GD
World J Urol; 2018 Mar; 36(3):417-425. PubMed ID: 29256020
[TBL] [Abstract][Full Text] [Related]
40. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
